People | March 07, 2023
Aptar appoints Julie Xing to its Board of Directors
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Subscribe To Our Newsletter & Stay Updated
